Remdesivir from failed Ebola drug to first FDA-approved COVID-19 antiviral: The medico-legal integration. [PDF]
Tsai TH.
europepmc +1 more source
Wastewater-Based Genomic Surveillance of SARS-CoV-2 Antiviral Resistance Determinants in Ontario: Towards a Scalable Framework for Population-Level Antiviral Resistance Monitoring. [PDF]
Lawal OU +10 more
europepmc +1 more source
Combination of Remdesivir and Ivermectin Exerts Highly Potent and Synergistic Antiviral Activity Against Murine Coronavirus and SARS-CoV-2 Infections. [PDF]
Lew RZZ +9 more
europepmc +1 more source
SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins. [PDF]
Shaw M, Fehr AR.
europepmc +1 more source
Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options. [PDF]
Mousavi S, Ardekani MB, Feizi A.
europepmc +1 more source
Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy Participants. [PDF]
Peng CC +6 more
europepmc +1 more source
Measles: A Narrative Review of Current Therapeutic Options and Implications for the Future. [PDF]
Papanikolopoulou A +2 more
europepmc +1 more source
Airway epithelia clear rhinovirus infection via two waves of cell extrusion. [PDF]
Fore F +5 more
europepmc +1 more source
Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection. [PDF]
Ellis S +18 more
europepmc +1 more source
Computational Identification of Potential RSV L-RdRp Inhibitors with Predicted Superior Activity and Safety Profiles over Remdesivir Using QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations. [PDF]
Xie Y, Jia R, Chen S, Li F, Sun G.
europepmc +1 more source

